Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents.

Paediatric Drugs
Karly P Garnock-Jones, Gillian M Keating

Abstract

Atomoxetine (Strattera(R)) is a selective norepinephrine (noradrenaline) reuptake inhibitor that is not classified as a stimulant, and is indicated for use in patients with attention-deficit hyperactivity disorder (ADHD). Atomoxetine is effective and generally well tolerated. It is significantly more effective than placebo and standard current therapy and does not differ significantly from or is noninferior to immediate-release methylphenidate; however, it is significantly less effective than the extended-release methylphenidate formulation OROS(R) methylphenidate (hereafter referred to as osmotically released methylphenidate) and extended-release mixed amfetamine salts. Atomoxetine can be administered either as a single daily dose or split into two evenly divided doses, has a negligible risk of abuse or misuse, and is not a controlled substance in the US. Atomoxetine is particularly useful for patients at risk of substance abuse, as well as those who have co-morbid anxiety or tics, or who do not wish to take a controlled substance. Thus, atomoxetine is a useful option in the treatment of ADHD in children and adolescents. The mechanism of action of atomoxetine is unclear, but is thought to be related to its selective inhibition...Continue Reading

References

Jun 1, 1995·Journal of Neurochemistry·D R GehlertS L Gackenheimer
Jul 11, 2002·Journal of the American Academy of Child and Adolescent Psychiatry·Christopher J KratochvilDavid Michelson
Nov 5, 2002·Journal of Clinical Pharmacology·Donna J BelleJennifer W Witcher
Nov 15, 2002·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Frank P BymasterKenneth W Perry
Mar 7, 2003·Clinical Pharmacology and Therapeutics·Stephan A ChalonYves Horsmans
Jun 14, 2003·Journal of Child and Adolescent Psychopharmacology·Jennifer W WitcherJoseph Biederman
Jul 17, 2003·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Joachim F WernickeJohn Heiligenstein
Jun 24, 2004·Journal of the American Academy of Child and Adolescent Psychiatry·David MichelsonJoseph Biederman
May 25, 2005·Clinical Pharmacokinetics·John-Michael SauerJennifer W Witcher
Jun 17, 2005·European Child & Adolescent Psychiatry·Helmut Remschmidt, UNKNOWN Global ADHD Working Group
Jun 22, 2005·Journal of the American Academy of Child and Adolescent Psychiatry·Margaret WeissAlbert J Allen
Jul 7, 2005·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Julie A Dopheide
Jul 19, 2005·Lancet·Joseph Biederman, Stephen V Faraone
Jul 22, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Donald L GilbertEric M Wassermann
Aug 23, 2005·Journal of the American Academy of Child and Adolescent Psychiatry·Christopher J KratochvilJoseph Biederman
Jan 24, 2006·Journal of the American Academy of Child and Adolescent Psychiatry·Timothy E WilensHaitao Gao
May 25, 2006·Journal of the American Academy of Child and Adolescent Psychiatry·Steven R PliszkaUNKNOWN TEXAS CONSENSUS CONFERENCE PANEL ON PHARMACOTHERAPY OF CHILDHOOD ATTENTION DEFICIT HYPERACTIVITY DISORDER
Jul 25, 2006·The Journal of Pediatrics·Timothy E WilensLouise R Levine
Jul 26, 2006·Journal of the American Academy of Child and Adolescent Psychiatry·Christopher J KratochvilDouglas L Gelowitz
Sep 28, 2006·Journal of the American Academy of Child and Adolescent Psychiatry·L Eugene ArnoldYaser Ramadan
Nov 15, 2006·Pediatrics·Jeffrey H NewcornUNKNOWN Atomoxetine Low-dose Study Group
Dec 30, 2006·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Mark L WolraichMelissa Doffing
Jan 24, 2007·Journal of the American Academy of Child and Adolescent Psychiatry·David MichelsonJames McCracken
Mar 28, 2007·Disease-a-month : DM·Donald E GreydanusDilip R Patel
Apr 5, 2007·Paediatric Drugs·Stephanie K A Blick, Gillian M Keating
Apr 24, 2007·Journal of the American Academy of Child and Adolescent Psychiatry·Laurence L GreenhillPeter D Feldman
May 11, 2007·Journal of Child and Adolescent Psychopharmacology·Christopher J KratochvilJulie Stoner
Jun 22, 2007·Journal of the American Academy of Child and Adolescent Psychiatry·Steven Pliszka, UNKNOWN AACAP Work Group on Quality Issues
Aug 2, 2007·Primary Care·Sreenivas Katragadda, Howard Schubiner

❮ Previous
Next ❯

Citations

Nov 12, 2013·European Child & Adolescent Psychiatry·Kayhan BahaliOzgur Orum
Feb 9, 2012·Attention Deficit and Hyperactivity Disorders·Heidi Lewis, James Lewis
Jul 5, 2013·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Sucharita S SomkuwarLinda P Dwoskin
Oct 23, 2012·Journal of Child and Adolescent Psychopharmacology·Chi-Yung Shang, Susan Shur-Fen Gau
Nov 12, 2013·Journal of Child and Adolescent Psychopharmacology·Murat YüceMeral Oran
Feb 5, 2011·Menopause : the Journal of the North American Menopause Society·C Neill EppersonThomas E Brown
Jun 11, 2011·BMC Medicine·Kevin M AntshelStephen V Faraone
Dec 24, 2011·International Journal of Adolescent Medicine and Health·Benjamin L HandenRameshwari Tumuluru
Dec 25, 2009·CNS Drugs·Karly P Garnock-Jones, Gillian M Keating
Jun 2, 2012·Mens Sana Monographs·Avinash De Sousa, Gurvinder Kalra
Jan 28, 2014·Psychopharmacology·Jessica J Stanis, Susan L Andersen
Nov 30, 2011·International Journal of Psychiatry in Clinical Practice·Luis MendezSoo Churl Cho
Jul 20, 2013·Expert Opinion on Pharmacotherapy·Nisha Warikoo, Stephen V Faraone
Mar 15, 2012·Expert Opinion on Drug Metabolism & Toxicology·Sophie DuongSharon B Wigal
Aug 30, 2014·Expert Opinion on Drug Safety·Annalisa CapuanoPietro Panei
Oct 5, 2013·Nuclear Medicine and Biology·M Reza MirbolookiJogeshwar Mukherjee
Dec 15, 2010·Journal of Pediatric Health Care : Official Publication of National Association of Pediatric Nurse Associates & Practitioners·Patricia Ryan-Krause
Jun 23, 2015·Pediatrics International : Official Journal of the Japan Pediatric Society·Ibrahim Cansaran TanidirVolkan Tuzcu
May 11, 2010·The Medical Clinics of North America·Ming-Horng Tsai, Yu-Shu Huang
Sep 30, 2014·Journal of Child and Adolescent Psychopharmacology·Himanshu UpadhyayaYoko Tanaka
Dec 1, 2015·Future Medicinal Chemistry·Horrick SharmaAloke Dutta
Feb 16, 2011·Paediatric Anaesthesia·Kathleen A NevilleGregory L Kearns
Apr 2, 2011·Human Psychopharmacology·Javad Mahmoudi-GharaeiToktam Faghihi
Apr 22, 2015·Attention Deficit and Hyperactivity Disorders·Adrian L Lopresti
Apr 4, 2015·Attention Deficit and Hyperactivity Disorders·Nathanel Zelnik, Ruth Terkel-Dawer
Jan 6, 2015·Wiley Interdisciplinary Reviews. Cognitive Science·Stephen P HinshawUNKNOWN For the MTA Cooperative Group
Apr 4, 2015·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Mark J MillanSven Ove Ögren
Jun 10, 2015·Sleep Medicine Clinics·John H Herman
Aug 26, 2014·European Archives of Psychiatry and Clinical Neuroscience·Jochen AntelJohannes Hebebrand

❮ Previous
Next ❯

Related Concepts

Related Feeds

Attention Disorders

Attention is involved in all cognitive activities, and attention disorders are reported in patients with various neurological diseases. Here are the latest discoveries pertaining to attention disorders.